Next-generation fetal blood group typing panel for safe precision medicine management of women with red cell and platelet antibodies

Pathology(2022)

引用 0|浏览1
暂无评分
摘要
Currently available non-invasive prenatal testing (NIPT) assays for fetal red cell and platelet antigens has shown clinical benefit in the management of at-risk pregnancies. However, the capacity for NIPT to predict the full range of antigens with clinically-significant maternal antibodies remains.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要